1. Home
  2. IVA vs LINC Comparison

IVA vs LINC Comparison

Compare IVA & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • LINC
  • Stock Information
  • Founded
  • IVA 2011
  • LINC 1946
  • Country
  • IVA France
  • LINC United States
  • Employees
  • IVA N/A
  • LINC N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • LINC Other Consumer Services
  • Sector
  • IVA Health Care
  • LINC Real Estate
  • Exchange
  • IVA Nasdaq
  • LINC Nasdaq
  • Market Cap
  • IVA 769.0M
  • LINC 732.0M
  • IPO Year
  • IVA 2020
  • LINC 2005
  • Fundamental
  • Price
  • IVA $4.21
  • LINC $20.72
  • Analyst Decision
  • IVA Strong Buy
  • LINC Strong Buy
  • Analyst Count
  • IVA 8
  • LINC 3
  • Target Price
  • IVA $16.13
  • LINC $26.00
  • AVG Volume (30 Days)
  • IVA 492.4K
  • LINC 303.7K
  • Earning Date
  • IVA 09-29-2025
  • LINC 11-10-2025
  • Dividend Yield
  • IVA N/A
  • LINC N/A
  • EPS Growth
  • IVA N/A
  • LINC 40.12
  • EPS
  • IVA N/A
  • LINC 0.45
  • Revenue
  • IVA $19,929,536.00
  • LINC $494,742,000.00
  • Revenue This Year
  • IVA N/A
  • LINC $14.51
  • Revenue Next Year
  • IVA N/A
  • LINC $8.40
  • P/E Ratio
  • IVA N/A
  • LINC $46.34
  • Revenue Growth
  • IVA N/A
  • LINC 16.90
  • 52 Week Low
  • IVA $2.11
  • LINC $14.10
  • 52 Week High
  • IVA $7.98
  • LINC $25.76
  • Technical
  • Relative Strength Index (RSI)
  • IVA 44.77
  • LINC 50.21
  • Support Level
  • IVA $3.55
  • LINC $17.29
  • Resistance Level
  • IVA $4.10
  • LINC $21.18
  • Average True Range (ATR)
  • IVA 0.28
  • LINC 1.06
  • MACD
  • IVA 0.00
  • LINC 0.15
  • Stochastic Oscillator
  • IVA 71.26
  • LINC 80.09

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

Share on Social Networks: